The microbiota-gut-brain axis in mild cognitive impairment and Alzheimer's disease: a scoping review of human studies

Alison Warren1, Zan Wynia2, Patrick G Corr1

  • 1The Frame-Corr Laboratory, Department of Clinical Research and Leadership, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

Insights

Gut dysbiosis, an imbalance in gut bacteria, is common in Alzheimer's disease (AD) and mild cognitive impairment (MCI). Interventions targeting the gut microbiome show potential for cognitive health.

Area of Science:

  • Microbiome Research
  • Neurological Disorders
  • Gastroenterology

Background:

  • Alzheimer's disease (AD) poses a significant global health burden.
  • Growing evidence links the gut microbiome to AD pathogenesis.
  • Mild cognitive impairment (MCI) is an early stage often preceding AD.

Purpose of the Study:

  • To conduct a scoping review of gut microbiome research in MCI and AD.
  • To examine the impact of dietary and probiotic interventions on the gut microbiome and cognition.
  • To identify research gaps and future directions in the field.

Main Methods:

  • Searched PubMed, Scopus, and Cochrane Library up to February 2023.
  • Included original research and systematic reviews/meta-analyses (human studies only).
  • Screened 4751 articles, with 58 meeting inclusion criteria using PRISMA-ScR guidelines.

Main Results:

  • Gut dysbiosis frequently observed in MCI and AD.
  • Increased abundance of Pseudomonadota and Actinomycetota in AD.
  • Reduced microbial diversity noted in some MCI/AD cases.
  • Probiotic and dietary interventions showed inconsistent but promising effects on cognition and microbiota.

Conclusions:

  • Gut dysbiosis is a prevalent feature in MCI and AD.
  • Specific microbial shifts are associated with cognitive decline.
  • Interventions modulating the gut microbiota-cognition axis warrant further investigation.
  • Standardized protocols and longitudinal human studies are crucial for causal inference and therapeutic development.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
222
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
254
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
249
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42